Cardiovascular toxicity risk assessment of tyrosine kinase inhibitors: a pharmacovigilance study using the VigiBase database.
Saved in:
| Title: | Cardiovascular toxicity risk assessment of tyrosine kinase inhibitors: a pharmacovigilance study using the VigiBase database. |
|---|---|
| Authors: | Igawa Y; Department of Clinical Pharmacology and Pharmacy, Okayama University, Okayama, Japan.; Department of Pharmacy, Okayama University Hospital, Okayama, Japan., Hamano H; Department of Clinical Pharmacology and Pharmacy, Okayama University, Okayama, Japan.; Department of Pharmacy, Okayama University Hospital, Okayama, Japan., Esumi S; Department of Clinical Drug Evaluation, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan., Takeda T; Department of Education and Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan., Kajizono M; Department of Pharmacy, Okayama City Hospital, Okayama, Japan., Kikuoka R; Department of Pharmacy, Okayama University Hospital, Okayama, Japan., Kimura I; Department of Pharmacy, Okayama University Hospital, Okayama, Japan., Zamami Y; Department of Clinical Pharmacology and Pharmacy, Okayama University, Okayama, Japan.; Department of Pharmacy, Okayama University Hospital, Okayama, Japan. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2024 Dec 02; Vol. 15, pp. 1472008. Date of Electronic Publication: 2024 Dec 02 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2024.1472008 |
